Top Tweets for #CheckpointInhibitor
What separates responders from non-responders? The big picture of ICI resistance. Vol.1👇 #Immunotherapy #CheckpointInhibitor #Oncology
https://t.co/QohQ093pNE
#ESMOGynae26: Data from two #ClinicalTrials provide long-term #EfficacyAndSafety evidence for the #CheckpointInhibitor dostarlimab, suggesting that immunotherapy may be used w/ curative intent in #EndometrialCancer. #ESMODailyReporter➡️https://t.co/Gaj65ghcVt
@GynCancerMD
Phase III trial results show periodic ctDNA screening after surgery can help guide a decision to begin adjuvant immunotherapy.
#BladderCancer #CheckpointInhibitor #ctDNA #ESMO2025 #immunotherapy #Tecentriq
https://t.co/Z4OKyStQn2
🔥 Hot take from #ACG2025: >5️⃣0️⃣% of colon adenomas appear within 7.5 months after immune #CheckpointInhibitor colitis.
We need “more proactive, risk-stratified approach to surveillance colonoscopy,” Dr. Tanvi Gupta @UTHealthHouston told Healio.
https://t.co/RDjIwnnOts
BriaCell announced updated Phase 2 survival data for its lead #immunotherapy candidate, Bria-IMT, in combination with an immune #checkpointinhibitor (#CPI). For more information, visit: https://t.co/hp0KYegGbo $BCTX $BCTXW
#metastaticbreastcancer #MBC
BriaCell announced updated results from its Phase 2 study of Bria-IMT™ in combination with #checkpointinhibitor in patients with advanced #metastaticbreastcancer (#MBC). Find more information: https://t.co/YxjNOLMiHw $BCTX $BCTXW
@JankovicK (2/2) ⏳ 2-yr EFS & OS climb high,
Surgery stays safe, no goodbye.
🏆 ESMO gave it an “A” in cure,
A new SoC that will endure.
A mountain scaled, a war well won—
The age of Imfinzi has begun. 🌄
#CancerCare #ESMO #CheckpointInhibitor #UroOnc #MedTwitter
In a study presented at #AACR25, investigators reported "encouraging early results from research investigating a potential way to help some cancer patients avoid surgery," @TIME describes. Discover: https://t.co/Atos1HBRif #CheckpointInhibitor #Immunotherapy @AACR
Fascinating data suggesting that oncological immune checkpoint inhibitors might increase the risk of transplant rejection, and that a washout period is needed to mitigate that risk. #hepatology #checkpointinhibitor
Original Article
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study
Moeckli et al.
#LiverX
https://t.co/CMp2tJZfzv
Dr. Veronika Bachanova (@umn_dom) on #CheckpointInhibitor resistance in #HodgkinLymphoma:
✅ 9p24.1 amplifications drive PD-1 & JAK2 overexpression
✅ CPI resistance via TME, genetic alterations & immune evasion
✅ Dual PD-1 & JAK2 blockade may enhance response
#DAVAWhistler
Why Immune Checkpoint Inhibitors do not work? - @CancerWorldmag
https://t.co/WtjOu76El7
#Cancer #CancerResearch #Immunotherapy #CheckpointInhibitor #OvarianCancer #MedX #MedNews #MedEd #Oncology #OncoDaily
New #JIPO research article "Lefitolimod in combination with ipilimumab in patients with advanced solid tumors: a phase I trial" by Hong, Curran, and Naing https://t.co/6qf92LlWTG #immunotherapy #checkpointinhibitor #phase1trial @DavidHongMD @ANaingMD
Pheast’s Director of CMC talks with @GENbio about how we are developing scalable manufacturing processes for PHST001, our anti-CD24 #macrophage #checkpointinhibitor, to move from R&D to #clinicaltrials.
Read the article here: https://t.co/0IRyWA3Z6f
#Pituitary complications of #CheckpointInhibitor use: Featured review in
#Endocrinology discusses mechanisms and management.
#cancer #FreeToView
@TheEndoSociety
https://t.co/Afd0djvHEO
SCI member @max_diehn & others found that detecting #ctDNA before, during, or after six months of consolidation #Checkpointinhibitor therapy is strongly associated with inferior outcomes. https://t.co/JKYHX8qHnJ @AshAlizadeh
More costly examples highlighting the need for personalized biology to predict efficacy + cut trial failure. Especially relevant given knowing whether a #CheckpointInhibitor will work is a solved problem with the @EpiSwitchCiRT blood test. Thanks @zklaassen_md @urotoday @KEYTRUDA #ESMO24
The honesty, thoughtfulness, and wit of @ChrisSweens1
Phase 3 trials of Immunotherapy in Prostate Cancer --
A Case Study of "Failed All-Comer Strategy"
⚡️8 negative trials
💰 >$700 million USD
👨🦰 7,305 patients
#ESMO24 @urotoday
Read Dr. Jie Liu discuss increased #thyroid dysfunction in pts on #TKI & PD(L)1 therapy
Review of Kobayashi et al. 2024 in Cancer Immunol Immunother
https://t.co/irDy0a0xaq
#ICI #IRAE #thyroiditis #hypothyroidism #checkpointinhibitor #medtwitter #endotwitter @afreenshariffmd
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.’s KVA12123 Novel anti-VISTA Checkpoint Inhibitor.
https://t.co/xz1vEc7iub
#Oncology #CheckpointInhibitor
Join us on June 10 for the Pharmacy Updates webinar - @NCCN
@ijman
#Cancer #CheckpointInhibitor #OralToxicities #Pharmacy #NCCN
https://t.co/cG83ddyJUy
Today we announced the first preclinical data for PHST001, an anti-CD24 #macrophage #checkpointinhibitor.
Read the release here: https://t.co/3CB0KiTi7o
If you’re at #PEGS2024, don’t miss our talk today at 1:15pm ET.
#PEGS24 #immunotherapy #cancer #oncology #CD24
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.1M followers
Taylor Swift
@taylorswift13
81.9M followers
Lady Gaga
@ladygaga
73.5M followers
Virat Kohli
@imvkohli
70.6M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.2M followers
X
@x
60.8M followers